News
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...
The superstar has been diagnosed with a brain condition called normal pressure hydrocephalus. Learn about symptoms, causes, ...
Videos available at [ Key points A 94-year-old man with parkinsonism, followed in our geriatric medicine clinic, presented for routine follow-up, during which his wife reported that he had a ...
A new study published in the journal Frontiers in Pharmacology has found that cannabidiol (CBD) may help delay the onset and ...
ABOUT CARVYKTI® (CILTACABTAGENE AUTOLEUCEL; CILTA-CEL) ...
Better Movement Clinic clients living with acute disabilities and illness are searching for alternative health care providers after the business abruptly collapsed.
1 Program of Physical Therapy, Department of Medical Rehabilitation Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia 2 King Salman Center for Disability ...
Results from all 117 patients dosed in the pivotal Phase 2 iMMagine-1 study of anito-cel demonstrated 97% ORR and 68% CR/sCR at a median follow-up of 12.6 months -- -- No delayed neurotoxicities ...
Methods: Tandem gait performance (10 consecutive tandem steps) was judged in 36 consecutive patients with Parkinson’s disease and 49 consecutive patients with atypical parkinsonism. Results: Only 9 ...
Materials and Methods:: We used two approaches: (1) concurrent administration during the development of parkinsonism and (2) pre-administration to explore a possible preventive action. The effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results